You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cesium-131

Showing 1 - 25 of 200
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HNSCC Trial in Cincinnati, Cleveland, Philadelphia (Cesium-131, Pembrolizumab)

Recruiting
  • HNSCC
  • Cincinnati, Ohio
  • +2 more
Oct 4, 2022

Prostate Cancer Trial in Pittsburgh (Focal prostate brachytherapy with Cesium-131)

Withdrawn
  • Prostate Cancer
  • Focal prostate brachytherapy with Cesium-131
  • Pittsburgh, Pennsylvania
    UPMC Mercy
Aug 23, 2022

Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early

Withdrawn
  • NSCLC
  • Non Small Cell Lung Cancer
  • Cesium-131 Brachytherapy Seed
  • New York, New York
    Weill Cornell Medical College
Mar 25, 2021

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Cleveland (Cesium 131)

Completed
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Cesium 131
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Dec 21, 2020

Recurrent Head and Neck Carcinoma Trial in Philadelphia (radiation, drug, procedure)

Active, not recruiting
  • Recurrent Head and Neck Carcinoma
  • Brachytherapy
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 7, 2020

Cesium-131 in Combination With External Beam Radiation for

Withdrawn
  • Prostate Cancer
    • Phoenix, Arizona
    • +8 more
    Apr 14, 2021

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)

    Withdrawn
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Jul 7, 2022

    Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +8 more
    • Iopofosine I 131 single dose
    • +2 more
    • Redlands, California
    • +42 more
    Dec 30, 2022

    Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

    Recruiting
    • Ganglioneuroblastoma
    • Neuroblastoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +18 more
    • Birmingham, Alabama
    • +158 more
    Sep 14, 2022

    Renal Tracer Elimination in Thyroid Cancer Patients Treated With

    Completed
    • Thyroid Carcinoma
      • Jena, Thüringen, Germany
        University Hospital Jena
      Dec 15, 2022

      B-ALL, DLBCL, B ALL Trial in New York (131-I Apamistamab, CAR T-cell)

      Recruiting
      • B-ALL
      • +10 more
      • 131-I Apamistamab
      • CAR T-cell
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Mar 7, 2022

      Thyroid Cancer Trial in Bialystok (metformin, Radioactive iodine (I-131))

      Not yet recruiting
      • Thyroid Cancer
      • Bialystok, Poland
        Department of Endocrinology, Diabetology and Internal Medicine,
      Jul 26, 2022

      High-Grade Glioma Trial in New York, Houston, Madison (CLR 131)

      Not yet recruiting
      • High-Grade Glioma
      • CLR 131
      • New York, New York
      • +2 more
      Nov 3, 2022

      Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,

      Recruiting
      • Thyroid Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Iodine-131 in Total(Near) Thyroidectomy Patients.

      Completed
      • Thyroidectomy
        • New Taipei City, Taiwan
          Far Eastern Memorial Hospital
        Feb 22, 2022

        Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,

        Active, not recruiting
        Has Results
        • Disseminated Neuroblastoma
        • +5 more
        • Birmingham, Alabama
        • +22 more
        Mar 3, 2022

        Agitation in Patients With Dementia of the Alzheimer's Type Trial in Worldwide (AVP-786)

        Recruiting
        • Agitation in Patients With Dementia of the Alzheimer's Type
        • Chandler, Arizona
        • +240 more
        Aug 23, 2022

        Follicular Lymphoma Trial in Chicago (Bortezomib and Tositumomab I-131)

        Terminated
        Has Results
        • Follicular Lymphoma
        • Bortezomib and Tositumomab I-131
        • Chicago, Illinois
          Rush University Medical Center
        Oct 6, 2021

        Thyroid, Cancer Trial in Seoul (alpha-lipoic acids)

        Withdrawn
        • Thyroid
        • Cancer
        • alpha-lipoic acids
        • Seoul, Korea, Republic of
          Asan Medical Center
        Jul 19, 2021

        Thyroid Cancer Trial in New York (131 I-iodine (131-I), 124 I-iodine (124-I))

        Active, not recruiting
        • Thyroid Cancer
        • 131 I-iodine (131-I), 124 I-iodine (124-I)
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Apr 1, 2022

        Gastrointestinal Tumors, Adenocarcinoma Trial in Worldwide (IMU-131, Cisplatin and either Fluorouracil (5-FU) or Capecitabine or

        Active, not recruiting
        • Gastrointestinal Neoplasms
        • Adenocarcinoma
        • IMU-131
        • Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine.
        • Tbilisi, Georgia
        • +21 more
        Jan 19, 2022

        Differentiated Thyroid Cancer Trial in Leiden (rhTSH-stimulated I-124 dosimetry, Intra-therapeutic I-131 dosimetry)

        Recruiting
        • Differentiated Thyroid Cancer
        • rhTSH-stimulated I-124 dosimetry
        • Intra-therapeutic I-131 dosimetry
        • Leiden, Zuid-Holland, Netherlands
          Leiden University Medical Center
        Apr 8, 2022

        Head Neck Cancer Trial in United Kingdom (recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH)

        Active, not recruiting
        • Head and Neck Cancer
        • recombinant thyroid-stimulating hormone
        • Radiodine ablation without rhTSH
        • Brighton, England, United Kingdom
        • +24 more
        Oct 13, 2021

        Chalazion Trial in United States (SUN-131 1.5% TDS, Placebo TDS)

        Completed
        Has Results
        • Chalazion
        • SUN-131 1.5% TDS
        • Placebo TDS
        • Chandler, Arizona
        • +64 more
        Aug 3, 2021